August 2, 2018
- Drug Trials Snapshots: TIBSOVO
- FDA Drug Shortages
- Atorvastatin Calcium Tablets (New - Discontinuation)
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Bumetanide Injection, USP (Updated - Currently in Shortage)
- Diltiazem Hydrochloride (Updated - Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated - Currently in Shortage)
- Isocarboxazid Tablets (Updated - Currently in Shortage)
- Ketamine Injection (Updated - Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated - Currently in Shortage)
- Ondansetron Hydrochloride Injection (Updated - Currently in Shortage)
- Pantoprazole (Protonix) Powder for Injection (Currently in Shortage)
- Phenytoin Sodium Injection, USP (Updated - Currently in Shortage)
- Progesterone Injection, USP (Updated - Currently in Shortage)
- Promethazine (Phenergan) Injection (Updated - Currently in Shortage)
- Sodium Chloride Injection USP, 0.9% Vials (New - Currently in Shortage)
No hay comentarios:
Publicar un comentario